These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10933772)

  • 1. Intravenous pulse methylprednisolone in the treatment of uveitis associated with multiple sclerosis.
    Wakefield D; Jennings A; McCluskey PJ
    Clin Exp Ophthalmol; 2000 Apr; 28(2):103-6. PubMed ID: 10933772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.
    ; Kempen JH; Altaweel MM; Drye LT; Holbrook JT; Jabs DA; Sugar EA; Thorne JE
    Ophthalmology; 2015 Oct; 122(10):1967-75. PubMed ID: 26298715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Injectable Fluocinolone Acetonide Long-Acting Implant for Noninfectious Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Two-Year Results.
    Jaffe GJ; Lin P; Keenan RT; Ashton P; Skalak C; Stinnett SS
    Ophthalmology; 2016 Sep; 123(9):1940-8. PubMed ID: 27421623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose intravenous steroid pulse therapy in ocular involvement of Behcet's disease: a pilot double-blind controlled study.
    Mohammadi M; Shahram F; Shams H; Akhlaghi M; Ashofteh F; Davatchi F
    Int J Rheum Dis; 2017 Sep; 20(9):1269-1276. PubMed ID: 28524639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ophthalmic manifestations in familial Mediterranean fever: a case series of 6 patients.
    Yazici A; Ozdal P; Yuksekkaya P; Elgin U; Teke MY; Sari E
    Eur J Ophthalmol; 2014; 24(4):593-8. PubMed ID: 24338581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunosuppressants used in a steroid-sparing strategy for childhood uveitis.
    Schatz CS; Uzel JL; Leininger L; Danner S; Terzic J; Fischbach M
    J Pediatr Ophthalmol Strabismus; 2007; 44(1):28-34. PubMed ID: 17274332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Initial evaluation of subcutaneous daclizumab treatments for noninfectious uveitis: a multicenter noncomparative interventional case series.
    Nussenblatt RB; Peterson JS; Foster CS; Rao NA; See RF; Letko E; Buggage RR
    Ophthalmology; 2005 May; 112(5):764-70. PubMed ID: 15878055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of uveitis presenting for the first time in the elderly: analysis of 91 patients in a tertiary center.
    Grégoire MA; Kodjikian L; Varron L; Grange JD; Broussolle C; Seve P
    Ocul Immunol Inflamm; 2011 Aug; 19(4):219-26. PubMed ID: 21770796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical treatment of macular edema in patients with uveitis.
    Rojas B; Zafirakis P; Christen W; Markomichelakis NN; Foster CS
    Doc Ophthalmol; 1999; 97(3-4):399-407. PubMed ID: 10896356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High dose intravenous steroid therapy for severe posterior segment uveitis in Behçet's disease.
    Toker E; Kazokoğlu H; Acar N
    Br J Ophthalmol; 2002 May; 86(5):521-3. PubMed ID: 11973245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic granulomatous anterior uveitis associated with multiple sclerosis.
    Acar MA; Birch MK; Abbott R; Rosenthal AR
    Graefes Arch Clin Exp Ophthalmol; 1993 Mar; 231(3):166-8. PubMed ID: 8462890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous methylprednisolone induces rapid improvement in non-infectious uveitis: a multicentre study of 112 patients.
    Vegas-Revenga N; Martín-Varillas JL; Calvo-Río V; González-Mazón I; Sánchez-Bilbao L; Beltrán E; Fonollosa A; Maíz O; Blanco A; Cordero-Coma M; Ortego N; Torre I; Francisco Hernández F; Muñoz-Fernández S; Esteban Ortega MM; Diaz-Llopis M; Cañal J; Ventosa JA; Demetrio-Pablo R; Agudo-Bilbao M; Domínguez-Casas L; Hernández JL; Castañeda S; González-Gay MA; Blanco R
    Clin Exp Rheumatol; 2022 Jan; 40(1):142-149. PubMed ID: 33666160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon as a treatment for uveitis associated with multiple sclerosis.
    Becker MD; Heiligenhaus A; Hudde T; Storch-Hagenlocher B; Wildemann B; Barisani-Asenbauer T; Thimm C; Stübiger N; Trieschmann M; Fiehn C
    Br J Ophthalmol; 2005 Oct; 89(10):1254-7. PubMed ID: 16170111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and Efficacy of Adalimumab in Patients with Noninfectious Uveitis in an Ongoing Open-Label Study: VISUAL III.
    Suhler EB; Adán A; Brézin AP; Fortin E; Goto H; Jaffe GJ; Kaburaki T; Kramer M; Lim LL; Muccioli C; Nguyen QD; Van Calster J; Cimino L; Kron M; Song AP; Liu J; Pathai S; Camez A; Schlaen A; van Velthoven MEJ; Vitale AT; Zierhut M; Tari S; Dick AD
    Ophthalmology; 2018 Jul; 125(7):1075-1087. PubMed ID: 29429764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Post-streptococcal uveitis].
    Viel A; Kolyvras N; Catherine J; Relvas L; Judice M; Caspers L; Willermain F
    J Fr Ophtalmol; 2011 Apr; 34(4):256.e1-6. PubMed ID: 21444125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of Treating Pediatric Uveitis With Dexamethasone Implants.
    Tomkins-Netzer O; Talat L; Seguin-Greenstein S; Bar A; Lightman S
    Am J Ophthalmol; 2016 Jan; 161():110-5.e1-2. PubMed ID: 26478217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined fluocinolone acetonide intravitreal insertion and glaucoma drainage device placement for chronic uveitis and glaucoma.
    Malone PE; Herndon LW; Muir KW; Jaffe GJ
    Am J Ophthalmol; 2010 May; 149(5):800-6.e1. PubMed ID: 20189158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone intravitreal implant (Ozurdex®) for pediatric uveitis.
    Sella R; Oray M; Friling R; Umar L; Tugal-Tutkun I; Kramer M
    Graefes Arch Clin Exp Ophthalmol; 2015 Oct; 253(10):1777-82. PubMed ID: 26228441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Safety and Efficacy of Adalimumab in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis.
    Suhler EB; Jaffe GJ; Fortin E; Lim LL; Merrill PT; Dick AD; Brezin AP; Nguyen QD; Thorne JE; Van Calster J; Cimino L; Adan A; Goto H; Kaburaki T; Kramer M; Vitale AT; Kron M; Song AP; Liu J; Pathai S; Douglas KM; Schlaen A; Muccioli C; Van Velthoven MEJ; Zierhut M; Rosenbaum JT
    Ophthalmology; 2021 Jun; 128(6):899-909. PubMed ID: 33157077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Outcomes of Treatment with Biological Agents in Eyes with Refractory, Active, Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis.
    Al-Janabi A; El Nokrashy A; Sharief L; Nagendran V; Lightman S; Tomkins-Netzer O
    Ophthalmology; 2020 Mar; 127(3):410-416. PubMed ID: 31607412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.